Recent Activity

Loading...

SYRE

Spyre Therapeutics, Inc · NASDAQ

Performance

+7.42%

1W

+4.22%

1M

+62.79%

3M

+278.38%

6M

+75.65%

YTD

+908.0%

1Y

Profile

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Investment Analysis Report: SYRE

Overview:

SYRE is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $837.25 million. In this report, we will conduct a detailed analysis of SYRE's financial health, earnings and revenue growth, profitability, operating margi...

See more ...

Technical Analysis of SYRE 2024-05-10

Overview:

In analyzing the technical indicators for SYRE stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide inves...

See more ...

Recent News & Updates